Top Markets
Coin of the day
Enveric Biosciences, Inc. Enveric Biosciences, Inc.

Enveric Biosciences, Inc.

ENVB
Rank in Stocks #38575
Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse... Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for treating osteoarthritis, and EVM-101 and EVM-201, which are intended to alleviate cancer-related distress. Furthermore, EVM-301 is under development for a mental health indication, alongside EV102, a cannabinoid cream formulated for topical skin application. Rounding out their portfolio is EV101, a novel combination therapy integrating cannabinoids with chemotherapy. This innovative company is based in Naples, Florida.
Share Price
$1.48
Market Cap
$883.58K
Change (1 day)
-1.99%
Change (1 year)
-88.89%
Country
US
Trade Enveric Biosciences, Inc. (ENVB)

Category

Stock price history for Enveric Biosciences, Inc. (ENVB)
Highest end of day price: $1.53 on 2026-08-01

Lowest end of day price: $4.75M on 2005-12-01
Stock price history of Enveric Biosciences, Inc. from 2005 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -15.21%
2025 -91.07%
2024 -76.28%
2023 -38.51%
2022 -95.86%
2021 -83.62%
2020 -22.41%
2019 -58.83%
2018 -91.51%
2017 -49.55%
2016 -1.21%
2015 416.23%
2014 5.31%
2013 356.80%
2012 -76.68%
2011 39.62%
2010 43.94%
2009 -80.84%
2008 -55.69%
2007 72.79%
2006 -43.88%
2005 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$507.41 30.01%
US
$848.17 30.00%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE